Somatropin biobetter (HanAll Biopharma)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameSomatropin biobetter (HanAll Biopharma)
Drug Alias NameOral hGH - HanAll BiopharmahGH - HanAll BioPharmaHanTropinResist-hGHVitatropin +[6] 
ClassificationBiologics
Mechanisms of ActionGrowth hormone receptor agonists
TargetsGrowth hormone receptor
Therapy Area/IndicationsGrowth hormone deficiency
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNautilus BiotechHanall
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNautilus BiotechHanall
Active IndicationsN/A
Inactive IndicationsGrowth hormone deficiency

Other Information

ATC CodeN/A
Related LinksN/A